Enfusion, Inc. (NYSE:ENFN) Stock Position Raised by Scalar Gauge Management LLC

Scalar Gauge Management LLC lifted its position in Enfusion, Inc. (NYSE:ENFN) by 21.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 613,513 shares of the company’s stock after buying an additional 110,000 shares during the quarter. Enfusion comprises 3.0% of Scalar Gauge Management LLC’s investment portfolio, making the stock its 11th largest holding. Scalar Gauge Management LLC owned 0.48% of Enfusion worth $5,227,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Brown Capital Management LLC boosted its position in Enfusion by 6.5% during the fourth quarter. Brown Capital Management LLC now owns 11,817,661 shares of the company’s stock worth $114,631,000 after purchasing an additional 724,502 shares during the period. Wasatch Advisors LP lifted its position in shares of Enfusion by 34.2% in the 1st quarter. Wasatch Advisors LP now owns 792,083 shares of the company’s stock worth $7,327,000 after acquiring an additional 201,771 shares during the period. Dimensional Fund Advisors LP lifted its position in Enfusion by 57.5% in the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock worth $4,466,000 after purchasing an additional 191,436 shares during the period. Renaissance Technologies LLC boosted its position in shares of Enfusion by 167.6% during the 2nd quarter. Renaissance Technologies LLC now owns 97,100 shares of the company’s stock valued at $827,000 after acquiring an additional 60,811 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Enfusion by 1.4% during the first quarter. Vanguard Group Inc. now owns 3,653,189 shares of the company’s stock valued at $33,792,000 after purchasing an additional 51,670 shares in the last quarter. Institutional investors and hedge funds own 81.05% of the company’s stock.

Enfusion Price Performance

Shares of NYSE:ENFN opened at $9.50 on Tuesday. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of 316.67, a price-to-earnings-growth ratio of 2.23 and a beta of 0.90. The business’s fifty day moving average price is $8.54 and its two-hundred day moving average price is $8.88. Enfusion, Inc. has a fifty-two week low of $7.52 and a fifty-two week high of $10.45.

Enfusion (NYSE:ENFN) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The business had revenue of $49.46 million during the quarter, compared to the consensus estimate of $50.27 million. Enfusion had a net margin of 1.98% and a return on equity of 6.17%. Research analysts expect that Enfusion, Inc. will post 0.07 EPS for the current fiscal year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.